The Current Ratio as of September 2024 (TTM) for Centessa Pharmaceuticals plc (CNTA) is 13.29

According to Centessa Pharmaceuticals plc’s latest financial reports and current stock price. The company's current Current Ratio is 13.29. This represents a change of 29.10% compared to the average of 10.29 of the last 4 quarters.

Centessa Pharmaceuticals plc (CNTA) Historical Current Ratio (quarterly & annually)

How has CNTA Current Ratio performed in the past?

The mean historical Current Ratio of Centessa Pharmaceuticals plc over the last ten years is 8.74. The current 13.29 Current Ratio has changed 15.10% with respect to the historical average. Over the past ten years (40 quarters), CNTA's Current Ratio was at its highest in in the June 2021 quarter at 26.61. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Centessa Pharmaceuticals plc (CNTA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Centessa Pharmaceuticals plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Centessa Pharmaceuticals plc (CNTA) Average Current Ratio

How has CNTA Current Ratio performed in the past?

The current Current Ratio of Centessa Pharmaceuticals plc (CNTA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Centessa Pharmaceuticals plc (CNTA) Current Ratio vs. Peers

How is CNTA’s Current Ratio compared to its peers?

Centessa Pharmaceuticals plc’s Current Ratio is greater than Century Therapeutics, Inc. (10.62), less than Edgewise Therapeutics, Inc. (30.24), greater than C4 Therapeutics, Inc. (5.09), greater than Mineralys Therapeutics, Inc. (11.20), less than Cullinan Oncology, Inc. (28.87), greater than NewAmsterdam Pharma Company N.V. (9.83), greater than Sutro Biopharma, Inc. (3.41), greater than Opthea Limited (2.94), greater than HilleVax, Inc. (5.14), less than Nuvalent, Inc. (17.44), greater than Tarsus Pharmaceuticals, Inc. (7.03), greater than Genfit S.A. (2.94), greater than Gracell Biotechnologies Inc. (7.73), less than Theseus Pharmaceuticals, Inc. (29.93), greater than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), less than Erasca, Inc. (16.79), less than Crinetics Pharmaceuticals, Inc. (16.09), greater than Entrada Therapeutics, Inc. (5.70), less than Disc Medicine, Inc. (25.02), greater than Larimar Therapeutics, Inc. (10.93),

Build a custom stock screener for Centessa Pharmaceuticals plc (CNTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Centessa Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Centessa Pharmaceuticals plc (CNTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Centessa Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.